Nora Alorf

Saudi Food & Drug Authority, Saudi Arabia

Poster(s):

• (A-227) Adverse Drug Events Associated with Pembrolizumab In Pediatric Oncology: Analysis of Global and Local Individual Case Safety Reports
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET